Mineralys Therapeutics, Inc. (MLYS) vs Septerna, Inc. (SEPN)
- Mineralys Therapeutics, Inc. MLYS 21.35 +1.18%
- Septerna, Inc. SEPN 40.83 +0.17%
Mineralys Therapeutics, Inc. and Septerna, Inc. are both Biotechnology companies. Mineralys Therapeutics, Inc. and Septerna, Inc. are of similar size ($1.9B and $1.9B). Mineralys Therapeutics, Inc. has the higher net margin (0.00% vs −24.5%) and the higher return on invested capital (0.00% vs −189.0%). Across the 13 metrics below, Septerna, Inc. leads on 7 and Mineralys Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | MLYS | SEPN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.77% |
| Operating margin | 0.00% | (44.04%) | 0.00% |
| Net margin | 0.00% | (24.51%) | 0.00% |
| Free cash flow margin | 0.00% | 118.93% | 0.00% |
| Return on equity | (80.88%) | (6.34%) | (54.09%) |
| Return on assets | (69.67%) | (4.94%) | (47.78%) |
| Return on invested capital | 0.00% | (189.01%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack